(S)-(+)-Epichlorohydrin CAS 67843-74-7 Assay ≥99.5% ee ≥99.5% High Purity
Ukunikezela Komkhiqizi Ngokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
I-Epichlorohydrin CAS 106-89-8
(R)-(-)-Epichlorohydrin CAS 51594-55-9
(S)-(+)-Epichlorohydrin CAS 67843-74-7
I-Chiral Compounds, Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo
Igama Lekhemikhali | (S)-(+)-Epichlorohydrin |
Omqondofana | (S)-Epichlorohydrin;(S)-(+)-2-(Chloromethyl)oxirane;(S)-Chloromethyloxirane;(S)-3-Chloropropylene oxide;(S)-1-Chloro-2,3-epoxypropane |
Inombolo ye-CAS | 67843-74-7 |
Inombolo yeCAT | I-RF-CC203 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C3H5ClO |
Isisindo samangqamuzana | 92.52 |
Ukuminyana | 1.180 g/mL ku-20℃ (lit.) |
Iphuzu elibilayo | 112℃ |
I-Flash Point | 31℃ |
I-Refractive Index | 1.44 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Uketshezi Olungenambala Kuya Kuphuzi Okuphuzi |
Indlela Yokuhlola / Yokuhlaziya | ≥99.5% (GC) |
I-Enantiomeric Excess | ee ≥99.5% |
Umswakama (KF) | ≤0.30% |
I-Chroma (Pt-Co) Hazen | ≤30 |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Chiral Compounds;Pharmaceutical Intermediates |
(S)-Epichlorohydrin (CAS: 67843-74-7) Umzila Wokwenziwa
Iphakheji: Ibhodlela, Umgqomo, 25kg/Umgqomo, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomphakeli we-(S)-(+)-Epichlorohydrin (CAS: 67843-74-7) enekhwalithi ephezulu, ingeyesikhungo semithi futhi ingasetshenziselwa ukuhlanganiswa kwe ama-chiral intermediates kanye nezidakamizwa ze-chiral.
I-Shanghai Ruifu Chemical Co., Ltd. idlala indima ebalulekile kumakhemikhali e-chiral, inkampani izibophezele ekukhiqizeni ama-chiral compounds.Imikhiqizo yethu inconywa kakhulu ngamakhasimende.
(S)-(+)-Epichlorohydrin (CAS: 67843-74-7) ibhulokhi yokwakha i-chiral, esetshenziselwa ukuhlanganiswa okuphelele kwe-Macquarimicins kanye nokuhlanganiswa okuphelele kwe-macrolide RK-397.I-Chiral building block kuma-enantioselective syntheses we-hydroxyisoxazolidines kanye (+) -cis-sylvaticin, i-ejenti engase ibe khona yokulwa nesimila.Isetshenziselwa ukukhiqiza ama-inhibitors we-fatty acid oxidation njengama-modulators angaba khona we-metabolic.